Protalix BioTherapeutics, Inc. Deferred Revenue Recognized
Protalix BioTherapeutics, Inc. (PLX) reported Deferred Revenue Recognized of $4.50 million for the 3-month period ending 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2020-03-12
- Protalix BioTherapeutics, Inc. contract with customer, liability, revenue recognized for the quarter ending 2019-12-31 was $4.50M.
- Protalix BioTherapeutics, Inc. contract with customer, liability, revenue recognized for the quarter ending 2019-03-31 was -$6.91M.
- Protalix BioTherapeutics, Inc. contract with customer, liability, revenue recognized for the quarter ending 2018-03-31 was -$2.16M.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month |
|---|---|---|---|
| 2019-12-31 | $4.50M 10-K · filed 2020-03-12 | ||
| 2019-09-30 | -$24.85M 10-Q · filed 2019-11-07 | ||
| 2019-06-30 | -$15.73M 10-Q · filed 2019-08-08 | ||
| 2019-03-31 | -$6.91M 10-Q · filed 2019-05-06 | ||
| 2018-09-30 | -$16.66M 10-Q · filed 2019-11-07 | ||
| 2018-06-30 | -$4.99M 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | -$2.16M 10-Q · filed 2019-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |